Prescription drug · ANDA
Glipizide NDC 82804-959
Glipizide 5 mg/1 · Tablet · Oral · Proficient Rx LP
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 82804-959-00 | 82804095900 | 100 TABLET in 1 BOTTLE (82804-959-00)Marketed from Jan 12, 2026 | |
| 82804-959-11 | 82804095911 | 1000 TABLET in 1 BOTTLE (82804-959-11)Marketed from Jan 12, 2026 | |
| 82804-959-30 | 82804095930 | 30 TABLET in 1 BOTTLE (82804-959-30)Marketed from Jan 12, 2026 | |
| 82804-959-55 | 82804095955 | 500 TABLET in 1 BOTTLE (82804-959-55)Marketed from Jan 12, 2026 | |
| 82804-959-60 | 82804095960 | 60 TABLET in 1 BOTTLE (82804-959-60)Marketed from Jan 12, 2026 | |
| 82804-959-72 | 82804095972 | 120 TABLET in 1 BOTTLE (82804-959-72)Marketed from Jan 12, 2026 | |
| 82804-959-90 | 82804095990 | 90 TABLET in 1 BOTTLE (82804-959-90)Marketed from Jan 12, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Glipizide
- Generic name (nonproprietary)
- glipizide
- Active ingredients
- Glipizide — 5 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Proficient Rx LP
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 074378
- Marketing start
- Listing expires
- Other FDA classes
- Sulfonylurea Compounds (Chemical structure)
- Identifiers
- Product ID 82804-959_f5d7a98c-d1d4-43b9-8d7e-830a33ae0c24SPL ID f5d7a98c-d1d4-43b9-8d7e-830a33ae0c24SPL set ID f5d7a98c-d1d4-43b9-8d7e-830a33ae0c24RxCUI 310488, 310490UNII X7WDT95N5CUPC 0382804960309, 0382804959303
- Pharmacologic class
- Sulfonylurea
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N482804095900followed by a unit qualifier and the quantityPackage 82804-0959-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Glipizide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 074378
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Glipizide | Glipizide 10 mg/1 | TabletOral | Proficient Rx LP | 82804-960 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-4178 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-3133 |
| Glipizide | Glipizide 5 mg/1 | TabletOral | Oxford Pharmaceuticals, LLC | 69584-309 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | Oxford Pharmaceuticals, LLC | 69584-310 |
| Glipizide | Glipizide 10 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-4061 |